keyword
https://read.qxmd.com/read/33790341/hydrogen-peroxide-h-2-o-2-mediated-activation-of-mtorc2-increases-intracellular-na-concentration-in-the-renal-medullary-thick-ascending-limb-of-henle
#21
JOURNAL ARTICLE
Nadezhda N Zheleznova, Vikash Kumar, Theresa Kurth, Allen W Cowley
Hydrogen peroxide (H2 O2 ) production in the renal outer medulla is an important determinant of renal medullary blood flow and blood pressure (BP) salt-sensitivity in Dahl salt-sensitive (SS) rats. The mechanisms and pathways responsible for these actions are poorly understood. Recently, we have discovered that the mTOR complex 2 (mTORC2) plays a critical role in BP salt-sensitivity of SS rats by regulating Na+ homeostasis. PP242, an inhibitor of mTORC1/2 pathways exhibits potent natriuretic actions and completely prevented salt-induced hypertension in SS rats...
March 31, 2021: Scientific Reports
https://read.qxmd.com/read/33562337/molecular-aspects-of-the-isolated-limb-infusion-procedure
#22
REVIEW
Jüri Teras, Michael J Carr, Jonathan S Zager, Hidde M Kroon
For decades, isolated limb infusion (ILI) and hyperthermic isolated limb perfusion (HILP) have been used to treat melanoma in-transit metastases and unresectable sarcoma confined to the limb utilizing the effect of loco-regional high-dose chemotherapy to the isolated limb. Both procedures are able to provide high response rates in patients with numerous or bulky lesions in whom other loco-regional treatments are becoming ineffective. In comparison to systemic therapies, on the other hand, ILI and HILP have the advantage of not being associated with systemic side-effects...
February 7, 2021: Biomedicines
https://read.qxmd.com/read/33529083/durability-of-complete-response-to-intralesional-interleukin-2-for-in-transit-melanoma
#23
JOURNAL ARTICLE
Sami Khoury, Gregory C Knapp, Allison Fyfe, Jose Monzon, Claire Temple-Oberle, Gregory J McKinnon
BACKGROUND: Intralesional injection of interleukin-2 (IL-2) for in-transit melanoma (ITM) is associated with a high rate of complete response. However, there is a paucity of data on treatment durability and long-term outcomes. OBJECTIVES: To provide long-term data on patients with a complete response to IL-2 therapy for ITM. METHODS: Consecutive patients with ITM, treated with intralesional IL-2 therapy, at the Tom Baker Cancer Center were identified from April 2009 to August 2019...
July 2021: Journal of Cutaneous Medicine and Surgery
https://read.qxmd.com/read/33288404/intravenous-mannitol-reduces-intracompartmental-pressure-following-tibia-fractures-a-randomized-controlled-trial
#24
RANDOMIZED CONTROLLED TRIAL
Jerry Nesaraj, Viju Daniel Varghese, P R Boopalan, Manasseh Nithyananth, Thambu David Sudarsanam, Thilak Samuel Jepegnanam
PURPOSE: Impending compartment syndrome is a common event following closed tibia fractures, which can progress to sinister compartment syndrome. Fasciotomy is the only definitive treatment available, though it has its own drawbacks and complications. Medical management at present consists of limb elevation and adequate hydration. This study aims at determining whether intravenous administration of Mannitol reduced the intracompartmental pressure in patients with closed tibial fractures...
March 2021: Chinese Journal of Traumatology
https://read.qxmd.com/read/33087396/mechanism-of-diuresis-and-natriuresis-by-cannabinoids-evidence-for-inhibition-of-na-k-atpase-in-mouse-kidney-thick-ascending-limb-tubules
#25
JOURNAL ARTICLE
Joseph K Ritter, Ashfaq Ahmad, Shobha Mummalaneni, Zdravka Daneva, Sara K Dempsey, Ningjun Li, Pin-Lan Li, Vijay Lyall
The endocannabinoid, anandamide (AEA), stimulates cannabinoid receptors (CBRs) and is enriched in the kidney, especially the renal medulla. AEA infused into the renal outer medulla of mice stimulates urine flow rate and salt excretion. Here we show that these effects are blocked by the CBR type 1 (CB1) inverse agonist, rimonabant. Immunohistochemical analysis demonstrated the presence of CB1 in thick ascending limb (TAL) tubules. Western immunoblotting demonstrated the presence of CB1 (52 kDa) in the cortex and outer medulla of mouse kidney...
January 2021: Journal of Pharmacology and Experimental Therapeutics
https://read.qxmd.com/read/32918180/aso-author-reflections-return-to-isolated-limb-infusion-for-in-transit-melanoma
#26
JOURNAL ARTICLE
Michael J Carr, Hidde M Kroon, Jonathan S Zager
No abstract text is available yet for this article.
December 2020: Annals of Surgical Oncology
https://read.qxmd.com/read/32918177/oncologic-outcomes-after-isolated-limb-infusion-for-advanced-melanoma-an-international-comparison-of-the-procedure-and-outcomes-between-the-united-states-and-australia
#27
JOURNAL ARTICLE
Michael J Carr, James Sun, Hidde M Kroon, John T Miura, Georgia M Beasley, Norma E Farrow, Paul J Mosca, Michael C Lowe, Clara R Farley, Youngchul Kim, Syeda Mahrukh Hussnain Naqvi, Dennis A Kirichenko, Aishwarya Potdar, Hala Daou, Dean Mullen, Jeffrey M Farma, Michael A Henderson, David Speakman, Jonathan Serpell, Keith A Delman, B Mark Smithers, Brendon J Coventry, Douglas S Tyler, John F Thompson, Jonathan S Zager
BACKGROUND: Isolated limb infusion (ILI) is a minimally invasive procedure for delivering high-dose chemotherapy to extremities affected by locally advanced or in-transit melanoma. This study compared the outcomes of melanoma patients treated with ILI in the United States of America (USA) and Australia (AUS). METHODS: Patients with locally recurrent in-transit melanoma treated with ILI at USA or AUS centers between 1992 and 2018 were identified. Demographic and clinicopathologic characteristics were collected...
September 11, 2020: Annals of Surgical Oncology
https://read.qxmd.com/read/32830080/development-of-a-leakage-monitoring-system-in-isolated-limb-perfusion-with-portable-gamma-camera
#28
JOURNAL ARTICLE
A Agudo Martínez, C Calvo Morón, T Cambil Molina, F J García Gómez, P A de la Riva Pérez, L de la Cruz Merino, O Araji Tiliani, J A Terrón León, J Castro Montaño
Isolated limb perfusion (ILP) is a method for treating unresectable lesions of limbs in patients with melanoma or sarcoma by using high doses of tumor necrosis factor alpha and melphalan. These high doses can result in high systemic toxicity if there is a drug leak from the isolated circulation of the limb to the systemic. This makes it imperative to monitor the leakage rate (F[%]) during the infusion, currently performed with radiotracers. The objective of this work was to develop a leakage monitoring protocol as accurate as possible to ensure safe ILP...
August 21, 2020: Revista Española de Medicina Nuclear e Imagen Molecular
https://read.qxmd.com/read/32739218/factors-predicting-toxicity-and-response-following-isolated-limb-infusion-for-melanoma-an-international-multi-centre-study
#29
JOURNAL ARTICLE
Timothy J Kenyon-Smith, Hidde M Kroon, John T Miura, Jüri Teras, Georgia M Beasley, Dean Mullen, Norma E Farrow, Paul J Mosca, Michael C Lowe, Clara R Farley, Aishwarya Potdar, Hala Daou, James Sun, Jeffrey M Farma, Michael A Henderson, David Speakman, Jonathan Serpell, Keith A Delman, B Mark Smithers, Andrew Barbour, Brendon J Coventry, Douglas S Tyler, Jonathan S Zager, John F Thompson
INTRODUCTION: Isolated limb infusion (ILI) is a minimally-invasive procedure for delivering high-dose regional chemotherapy to treat melanoma in-transit metastases confined to a limb. The aim of this international multi-centre study was to identify predictive factors for toxicity and response. METHODS: Data of 687 patients who underwent a first ILI for melanoma in-transit metastases confined to the limb between 1992 and 2018 were collected at five Australian and four US tertiary referral centres...
July 13, 2020: European Journal of Surgical Oncology
https://read.qxmd.com/read/32669939/locoregional-management-of-in-transit-metastasis-in-melanoma-an-ontario-health-cancer-care-ontario-clinical-practice-guideline
#30
JOURNAL ARTICLE
F C Wright, S Kellett, N J Look Hong, A Y Sun, T P Hanna, C Nessim, C A Giacomantonio, C F Temple-Oberle, X Song, T M Petrella
Objective: The purpose of this guideline is to provide guidance on appropriate management of satellite and in-transit metastasis (itm) from melanoma. Methods: The guideline was developed by the Program in Evidence-Based Care (pebc) of Ontario Health (Cancer Care Ontario) and the Melanoma Disease Site Group. Recommendations were drafted by a Working Group based on a systematic review of publications in the medline and embase databases. The document underwent patient- and caregiver-specific consultation and was circulated to the Melanoma Disease Site Group and the pebc Report Approval Panel for internal review; the revised document underwent external review...
June 2020: Current Oncology
https://read.qxmd.com/read/32245735/sequencing-in-management-of-in-transit-melanoma-metastasis-diphencyprone-versus-isolate-limb-infusion
#31
JOURNAL ARTICLE
Michelle Ci Lo, Jennifer Garioch, Marc Ds Moncrieff
BACKGROUND: In-transit metastases (ITMs) in melanoma are associated with poor prognosis, however a significant proportion of these patients survive for extended periods without further disease progression. We routinely use locoregional treatment e.g. Diphencyprone (DPCP) and/or isolated limb infusion (ILI) as long-term palliation. This study aimed to identify correct sequencing of these therapies based on disease burden and progression. METHOD: Retrospective evaluation of all melanoma patients with ITMs treated with DPCP/ILI/both from 2010 to 2017 at our Cancer Centre was performed...
March 17, 2020: Journal of Plastic, Reconstructive & Aesthetic Surgery: JPRAS
https://read.qxmd.com/read/32228080/the-effects-of-dual-plating-on-the-vascularity-of-the-distal-femur
#32
JOURNAL ARTICLE
Natalie C Rollick, Naomi E Gadinsky, Craig E Klinger, Jeremy F Kubik, Jonathan P Dyke, David L Helfet, David S Wellman
AIMS: Dual plating of distal femoral fractures with medial and lateral implants has been performed to improve construct mechanics and alignment, in cases where isolated lateral plating would be insufficient. This may potentially compromise vascularity, paradoxically impairing healing. This study investigates effects of single versus dual plating on distal femoral vascularity. METHODS: A total of eight cadaveric lower limb pairs were arbitrarily assigned to either 1) isolated lateral plating, or 2) lateral and medial plating of the distal femur, with four specimens per group...
April 2020: Bone & Joint Journal
https://read.qxmd.com/read/32178691/antinociceptive-effect-of-intrathecal-injection-of-mir-9-5p-modified-mouse-bone-marrow-mesenchymal-stem-cells-on-a-mouse-model-of-bone-cancer-pain
#33
JOURNAL ARTICLE
Chao Zhu, Kun Wang, Zhi Chen, Yingchao Han, Hao Chen, Quan Li, Zude Liu, Lie Qian, Jun Tang, Hongxing Shen
BACKGROUND: A growing body of studies have indicated that bone marrow mesenchymal stem cells (BMSCs) have powerful analgesic effects in animal models of bone cancer pain. Here, we explored the molecular mechanisms underlying how BMSCs alleviate pain sensation in a mouse model of bone cancer pain. METHODS: C3H/HeN adult male mice were used to generate a bone cancer pain model. BMSCs were isolated from mouse bone marrow, modified by transfection with microRNA-9-5p (miR-9-5p), and infused into the spinal cord...
March 16, 2020: Journal of Neuroinflammation
https://read.qxmd.com/read/32162353/isolated-limb-infusion-institutional-protocol-and-implementation
#34
REVIEW
Michael J Carr, James Sun, Jonathan S Zager
Patients with unresectable cutaneous and soft tissue malignancies confined to a limb have many treatment options. Isolated limb infusion (ILI) is one therapeutic option whereby the extremity is isolated and perfused with high-dose chemotherapy through a percutaneously placed catheter-based procedure. A detailed description of the ILI protocol at the Moffitt Cancer Center is given. We have shown that ILI is a safe and effective treatment strategy for malignancies confined to an extremity.
July 2020: Journal of Surgical Oncology
https://read.qxmd.com/read/32152775/international-multicenter-experience-of-isolated-limb-infusion-for-in-transit-melanoma-metastases-in-octogenarian-and-nonagenarian-patients
#35
JOURNAL ARTICLE
Jüri Teras, Hidde M Kroon, John T Miura, Tim Kenyon-Smith, Georgia M Beasley, Dean Mullen, Norma E Farrow, Paul J Mosca, Michael C Lowe, Clara R Farley, Aishwarya Potdar, Hala Daou, James Sun, Michael Carr, Jeffrey M Farma, Michael A Henderson, David Speakman, Jonathan Serpell, Keith A Delman, B Mark Smithers, Andrew Barbour, Douglas S Tyler, Brendon J Coventry, Jonathan S Zager, John F Thompson
BACKGROUND: Isolated limb infusion (ILI) is used to treat in-transit melanoma metastases confined to an extremity. However, little is known about its safety and efficacy in octogenarians and nonagenarians (ON). PATIENTS AND METHODS: ON patients (≥ 80 years) who underwent a first ILI for American Joint Committee on Cancer seventh edition stage IIIB/IIIC melanoma between 1992 and 2018 at nine international centers were included and compared with younger patients (< 80 years)...
March 9, 2020: Annals of Surgical Oncology
https://read.qxmd.com/read/32144618/aso-author-reflection-isolated-limb-infusion-for-locally-advanced-melanoma-in-the-extremely-old-patient-is-safe-and-effective
#36
JOURNAL ARTICLE
Jüri Teras, Hidde M Kroon, Jonathan S Zager
No abstract text is available yet for this article.
March 6, 2020: Annals of Surgical Oncology
https://read.qxmd.com/read/32066314/below-the-ankle-arrival-time-as-a-novel-limb-tissue-perfusion-index-two-dimensional-perfusion-angiography-evaluation
#37
JOURNAL ARTICLE
Kuniyasu Ikeoka, Tetsuya Watanabe, Yukinori Shinoda, Tomoko Minamisaka, Hidetada Fukuoka, Hirooki Inui, Keisuke Ueno, Shiro Hoshida
Purpose: To identify lower limb 2-dimensional (2D) perfusion angiographic parameters that are related to skin perfusion pressure (SPP), a predictor of wound healing in patients with chronic limb-threatening ischemia (CLTI) undergoing below-the-knee (BTK) endovascular treatment (EVT). Materials and Methods: Thirty-three consecutive patients (mean age 74.5 years; 18 men) with 47 isolated BTK lesions in 33 limbs (Rutherford category 3-5) underwent EVT. Dorsal and plantar SPPs were measured before EVT and the day after...
April 2020: Journal of Endovascular Therapy
https://read.qxmd.com/read/31934586/soft-tissue-cancer-management-isolated-limb-infusion-for-sarcoma
#38
JOURNAL ARTICLE
Jyri Teras, Andrus Mägi, Marina Teras, Pille Pata, Roland M Teras, Neena Randhawa, Kristjan Kalling
BACKGROUND: Sarcoma is a heterogeneous group of malignancies comprising almost 80 subtypes of bone and soft tissue cancers. Previously, all subtypes were managed identically. Advancements in biological and genetic studies have revealed that sarcoma subtypes display varying characteristics and therefore require tailored treatments. Locally advanced soft tissue malignancies of both the trunk and the extremities can present significant challenges for treatment. At present, a negative surgical resection margin is the only definitive treatment despite attempts to use neoadjuvant and adjuvant therapies...
December 2019: Visceral Medicine
https://read.qxmd.com/read/31807277/intra-arterial-perfusion-based-therapies-for-regionally-metastatic-cutaneous-and-uveal-melanoma
#39
REVIEW
Kristy K Broman, Jonathan S Zager
Locoregional disease remains a challenging problem in cutaneous melanoma and uveal melanoma. Arterial-based chemoperfusion strategies enable regional therapy delivery with minimal systemic toxicity. Herein we discuss intra-arterial therapies for in-transit cutaneous melanoma of the extremity including hyperthermic-isolated limb perfusion and isolated limb infusion. We also discuss open (isolated hepatic perfusion) and percutaneous hepatic perfusion techniques for isolated liver metastases from uveal melanoma...
September 2, 2019: Melanoma Management
https://read.qxmd.com/read/31807274/topical-and-intralesional-therapies-for-in-transitmelanoma
#40
REVIEW
Michael A Henderson
This report surveys the role of topical and intralesional agents in the management of in-transit melanoma. The extent and progression of in-transit disease is highly variable and many patients can have a protracted period of locoregional control. These agents are useful in the management of patients who have progressed beyond local surgical excision in whom more aggressive therapies, such as isolated limb infusion or use of talimogene laherparepvec, are not appropriate or have failed. In general, these agents are modestly effective and associated with frequent but only minor toxicity...
September 2, 2019: Melanoma Management
keyword
keyword
54132
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.